Latest
News
2022
-
December 29, 2022
Read Article
Chitogenx reports its third quarter 2023 results -
November 9, 2022
Read Article
Chitogenx successfully completes initial portion of its u.s. phase i/ii rotator cuff repair clinical trial -
October 19, 2022
Read Article
Chitogenx signs memorandum of understanding with california medical innovations institute (calmi2) -
October 13, 2022
Read Article
Chitogenx launches second orthopedic development program in meniscus repair -
October 5, 2022
Read Article
Chitogenx to pursue sales of medical grade chitosan as new near-term revenue initiative -
September 29, 2022
Read Article
Chitogenx reports its second quarter 2023 results -
September 7, 2022
Read Article
Ortho regenerative technologies announces corporate name change to chitogenx -
July 27, 2022
Read Article
Ortho regenerative technologies announces enrollment of first patient in its u.s. phase i/ii rotator cuff tear repair clinical trial -
July 22, 2022
Read Article
Ortho regenerative technologies announces voting results of its annual general and special meeting of shareholders -
June 24, 2022
Read Article
Ortho regenerative technologies reports its first quarter 2023 results -
June 13, 2022
Read Article
Ortho regenerative technologies initiates patients recruitment for its u.s. phase i/ii rotator cuff tear repair clinical trial -
May 26, 2022
Read Article
Ortho regenerative technologies receives $500,000 axelys grant to advance ortho-m development for meniscus repair -
May 20, 2022
Read Article
Ortho regenerative technologies reports its fourth quarter and 2022 year-end results -
May 4, 2022
Read Article
Ortho regenerative technologies receives key u.s. composition and method patent for ortho-r soft tissue repair platform -
April 6, 2022
Read Article
Ortho regenerative technologies closes oversubscribed non-brokered private placement for $3.2 million -
March 24, 2022
Read Article
Ortho regenerative technologies to participate in the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest -
March 21, 2022
Read Article
Ortho regenerative technologies amends the terms of its $3 million non-brokered private placement of units -
March 15, 2022
Read Article
Ortho regenerative technologies announces executive leadership changes -
February 11, 2022
Read Article
Ortho regenerative technologies announces $3 million non-brokered private placement of units -
February 7, 2022
Read Article
Ortho regenerative technologies enters into a material transfer agreement with a global strategic medical company for its ortho-r rotator cuff tear repair phase i/ii u.s. clinical trial